E Azargun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
E Azargun has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Esmaeel Panahi Kokhdan
Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
1 shared publication Gh Akbari
Department of Physiology and Pharmacology, Yasuj University of Medical Sciences, Yasuj, Iran
1 shared publication- Hossein Sadeghi
Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
1 shared publication - Izadpanah Gheitasi
Department of Physiology, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
1 shared publication - Mahdokht Azizi
Department of Pathology, Yasuj University of Medical Sciences, Yasuj, Iran
1 shared publication
Latest Publications
- Open Access
- 1 March 2024
- Published by Apex Publishing in Armaghane Danesh
- Vol. 29 (2) , 172-184
Effect of Empagliflozin on Hepatotoxicity Induced by Cyclophosphamide in Male Rats
Background & aim: Cyclophosphamide (CP) is an immunosuppressive medication which is primarily used to manage and treatt of neoplasms, including breast cancer, lymphoma and Leukemia. CP as well possesses many side effects, including hepatotoxicity which leads to mitochondrial oxidative stress, cell death and hepatic necrosis. Empagliflozin (EMPA) is a Sodium-glucose cotransporter-2 inhibitor ...
- 1 March 2024
- Published by Apex Publishing in Armaghane Danesh
- Vol. 29 (2) , 172-184
Open AccessEffect of Empagliflozin on Hepatotoxicity Induced by Cyclophosphamide in Male Rats
Background & aim: Cyclophosphamide (CP) is an immunosuppressive medication which is primarily used to manage and treatt of neoplasms, including breast cancer, lymphoma and Leukemia. CP as well possesses many side effects, including hepatotoxicity which leads to mitochondrial oxidative stress, cell death and hepatic necrosis. Empagliflozin (EMPA) is a Sodium-glucose cotransporter-2 inhibitor ...